Janssen Pharmaceutica Nv

Justine M Kent

Wayne C Drevets

Peter De Boer

The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein Rto Rare described herein and wherein the compound is administered prior to sleep.

Methods of treating depression using orexin-2 receptor antagonists

The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein Rto Rare described herein and wherein the compound is administered prior to sleep. 

Growing community of inventors

Titusville, NJ, United States of America

Justine M Kent